Want to come on the show? Submit to be on the show here: https://tally.so/r/wdxljK Want to figure out which early adopters you should target? Get 3 free surgeon profiles where Alpha Sophia uses their database to give you the insights you need to sell https://www.alphasophia.com/omar For limited time only - Save $1,300 and Join the Medical Sales Network Effects Program! https://salesnetworkeffectsprogram.mykajabi.com/offers/FV2MG8sK?coupon_code=PRESIDENTSCLUBPODCAST Watch the "Medical Sales at Scale" webinar and learn about the Medical Sales Network Effects Program Follow The State of MedTech on: LinkedIn Facebook Twitter Instagram Follow Omar M. Khateeb on LinkedIn Instagram Twitter Facebook
00:00 Introduction to the 3D Scholars Program 02:29 The 3D Symposium: A Unique Gathering 07:42 Exploring the 3D Scholars Program 15:21 Challenges for Clinicians in Device Development 20:09 The Importance of Regulatory Knowledge 27:30 Curriculum Highlights and Expectations 33:29 Application Process and Diversity in Selection Showpad has been helping medtech marketers use data and content to empower sellers to grow pipeline. Learn more at Showpad.com/StateofMedtech For limited time only - Get the Medical Sales Network Effects Program for 60% off https://salesnetworkeffectsprogram.mykajabi.com/offers/FV2MG8sK?coupon_code=PODCAST2024 Follow The State of MedTech on: LinkedIn Instagram TikTok X Facebook Follow Omar M. Khateeb on LinkedIn Instagram TikTok X Facebook
In this episode of The State of MedTech, host Omar M. Khateeb sits down with Stuart Simpson, President and CEO of THINK Surgical, to explore how handheld robotics and open platforms are transforming orthopedic surgery.Stuart reveals the bold strategy behind the TMINI handheld robot, a device that’s rethinking what’s possible in orthopedic surgery by putting precision in the surgeon’s hands. From closing legacy programs to going all-in on handheld robotics, this conversation dives into leadership, risk-taking, and redefining industry norms.You’ll learn how THINK Surgical is positioning itself against giants like Stryker and Zimmer Biomet, why open-platform robotics could finally give surgeons more choice, and what the future looks like for robotics in ASCs and beyond.Episode Breakdown: 0:00 – Why handheld robotics is the future of orthopedics1:00 – Welcome back Stuart Simpson, CEO of THINK Surgical2:10 – From legacy robots to the TMINI handheld system3:40 – Closing one program to bet everything on TMINI5:00 – The bold decision to pivot THINK Surgical’s strategy6:20 – How handheld robots fit into surgical workflows8:00 – The rise of surgeon-centric design9:30 – Data insights: ease of use and CT-based planning10:50 – THINK Surgical’s guerrilla marketing campaign explained12:30 – Competing with Stryker’s Mako and Zimmer Biomet’s robotics15:00 – The end of closed systems in orthopedic robotics17:00 – The economics of open-platform robotics20:00 – Brand loyalty, implant choices, and surgeon autonomy23:00 – Zimmer Biomet’s robotics strategy and the Monogram deal25:00 – Handheld vs. autonomous robots: where the market is heading27:00 – Why simplicity wins in healthcare innovation29:00 – THINK Surgical’s growth and open platform goals33:00 – The next wave of innovation in orthopedic robotics35:00 – Turning competitors’ surgeons into THINK advocates37:00 – Leadership, bold bets, and the future of medtech40:00 – How to learn more and connect with THINK SurgicalAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#MedicalDevices #Robotics #Orthopedics #MedTechInsights #FutureOfSurgery
Jim Alecxih, CEO of Virtual Incision and former Intuitive Surgical executive, joins Omar Khateeb to discuss how the company’s MIRA platform, a portable, miniaturized robot is reshaping access to surgical robotics for hospitals and ambulatory surgery centers.Episode Breakdown: 00:00 Why Jim Alecxih returned to surgical robotics 02:18 The birth of Virtual Incision and its miniaturized robot 04:45 What smaller form factor really means for surgeons 07:02 Solving complexity: simplicity as the next medtech frontier 09:50 Bringing robotics to underserved hospitals and ASCs 13:10 Why Intuitive Surgical isn’t the competition anymore 15:45 Designing robots nurses can operate without reps 18:22 Building teams that thrive under pressure and adversity 22:11 Leadership lessons from Intuitive: clarity, calm, and communication 26:44 How to scale responsibly in a crowded medtech market 30:05 The Sun Tzu approach to strategy in surgical robotics 34:12 Competing by creating a new category, not fighting incumbents 38:29 Utilization over unit sales – the next robotics revolution 43:02 The real metric that defines success in medtech 48:26 What the next 24 months mean for surgical robotics 52:14 Virtual Incision’s roadmap and where the field is headed 55:40 Closing thoughts and what comes next in medtechAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/
Prostate cancer screening and diagnosis are changing fast. Dr. Geoffrey Sonn, Associate Professor of Urology and, by courtesy, of Radiology (Body MRI) at Stanford Medicine, joins Omar Khateeb to explore how AI and advanced imaging are reshaping how we detect, classify, and treat prostate cancer.From new biopsy techniques to AI-driven image interpretation, Dr. Sonn shares where the technology is today, what’s coming next, and how it could shift the balance between overdiagnosis and missed detection for millions of men worldwide.Episode Breakdown: 00:00 Welcome to State of MedTech with Dr. Geoffrey Sonn 00:45 How Stanford is redefining prostate-cancer imaging 02:14 Why early detection still fails too many men 04:01 The rise of AI-guided MRI-fusion biopsy 06:12 What surgeons actually see inside the scanner 08:04 From radiology to urology – bridging two worlds 09:58 How machine learning reads prostate tissue better than humans 12:06 Diagnosing without overtreating – the new balance in prostate care 14:10 How FDA clearance changed the pace of robotic diagnostics 16:02 Inside Stanford’s real-world AI validation studies 18:20 The problem with inconsistent imaging data 20:33 How startups can access anonymized clinical datasets 22:11 Why AI needs clinical context, not just clean data 24:00 The future of patient-specific risk prediction 26:02 MRI, ultrasound, and genomics – the convergence moment 27:51 What’s next for fusion-guided biopsy hardware 29:24 Reimbursement and adoption – the last big barrier 31:06 Training the next generation of AI-literate physicians 33:09 The role of public-private collaboration in MedTech innovation 35:10 How content and visibility accelerate research adoption 37:03 Dr. Sonn’s advice for MedTech founders entering imaging and AI 38:42 Closing thoughts – building trust in an algorithm-driven future 39:35 Outro – subscribe for more MedTech interviewsAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #AIinHealthcare #ProstateCancer #Radiology #Urology #HealthcareInnovation #StateofMedTech
From billion dollar M&A to FDA greenlights and the next wave of surgical AI, August was packed with major stories in medtech. Omar Khateeb & Nicholas Talamantes break down the month’s biggest moves, from Philips’ restructuring and Medtronic’s AI milestone to emerging neurotech players and investor trends shaping the rest of 2025.Episode Breakdown:00:00 Medtech is back: August + September recap 01:05 Omar’s new baby & the team’s European summer break 03:42 The $500 million quarter that proved Medtech’s engine is alive 05:09 Inside LSI’s Hot 25 Startups – how they rank the “hottest” companies 07:32 Why fundraising is still strong despite market headwinds 10:18 How much it really costs to build a surgical robot today 14:44 Thermo Fisher’s $1.5 billion move into organ transplantation 16:13 The sci-fi machine that keeps donor organs alive 18:54 August’s standout deals – AI, cardiology, and diagnostics 21:60 The rise of neuromodulation for hypertension 23:30 Ultrahuman & the $55 million AI cardio boom 25:60 HeartFlow IPO and the new era of cardiovascular investing 27:46 LSI Europe recap – the most promising innovators of 2024 29:04 Dell MedTech and other breakout companies to watch 33:28 Early-stage funding vs late-stage momentum – where money’s really going 36:54 Why investors are tightening on seed rounds but spending big on M&A 40:34 Summer slowdown or market shift? The funding pulse explained 42:09 Why Medtech might be entering its “golden age” of innovation 46:55 Why founders must create content before LSI – visibility equals trust 48:23 The M&A rush continues – Boston Scientific, Edwards, GE Healthcare 50:14 Why these acquisitions prove Medtech’s resilience 55:29 Robotics in stroke care – the next frontier after orthopedics 56:27 Edwards buys Victorious for $497 million – a heart failure game-changer 58:30 September highlights and the next wave of innovators 1:05:31 The $85 million ENT deal that shows minimally invasive is winning 1:07:07 Closing thoughts – Q3 predictions and M&A outlook 1:09:35 Tal Wurzel and the founders who keep building after billion-dollar exits 1:10:26 Outro – subscribe for next month’s State of MedTechAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #Healthcare #AI #Startups #DigitalHealth
Brain–computer interfaces are no longer science fiction. Matt Angle, Founder and CEO of Paradromics, joins Omar Khateeb to discuss how his company is building the world’s highest data–rate BCI.From his neuroscience roots at Stanford to raising capital in Austin, Matt shares how Paradromics is preparing for first-in-human trials in ALS patients, why data rate is the real bottleneck, how their platform stacks up against Neuralink, and why investors like Saudi Arabia’s NEOM are betting on this future.This episode covers the technology, the business, and the ethics behind connecting brains and machines.Episode Breakdown: 00:00 – What is a Brain-Computer Interface (BCI)? 01:02 – Introducing Paradromics and CEO Matt Angle 02:01 – Matt’s background: neuroscience at Heidelberg & Stanford 03:25 – Early BCI research and limitations of older systems 04:46 – Why Paradromics moved to Austin, Texas 06:28 – How Paradromics technology works: recording at the neuron level 09:50 – Surgical process for BCI implantation 11:08 – Paradromics vs. Neuralink: 10x higher data rates 11:53 – First application: restoring speech for ALS & paralysis patients 13:43 – Potential of BCIs in mental health and mood tracking 15:30 – Psychiatry’s challenge: lack of data vs. future of “brain work” 19:06 – Strategic partnership with Saudi fund NEOM 21:27 – Paradromics’ 3–5 year roadmap: hardware + applications 24:10 – Why BCIs could disrupt pharmaceuticals and drug dosing 26:09 – M&A potential in BCI: role of Medtronic, Abbott, Boston Scientific 29:03 – Why medical devices have staying power vs. drugs 30:12 – Market size: $400B+ opportunity for BCIs 32:16 – Cybersecurity and neural data protection 33:49 – The FDA BCI Collaborative Community 34:42 – Upcoming BCI Society meeting in Banff, Canada 35:11 – Closing thoughts & where to find Paradromics onlineAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #AFib #HealthcareInnovation #Cardiology #AIinHealthcare #StateofMedTech #MedicalDevices
What does it take to build a medtech startup that actually survives? Paul Grand, CEO and Founder of MedTech Innovator, has seen more than 14,000 companies apply to his program and helped over 800 raise billions in capital.In this episode, Paul joins Omar Khateeb to break down the top mistakes founders make, how investors really assess risk, why commercialization is the true valley of death, and what trends are shaping the next generation of medtech innovation.Episode Breakdown:00:00 – Introduction: Challenges of the MedTech space01:19 – Guest introduction: Paul Grand, CEO & Founder of MedTech Innovator02:18 – Paul Grand’s background and early career in tech & medtech03:38 – Transition into venture capital and working with innovators05:08 – Early interest in Brain-Computer Interfaces & AI in medtech07:11 – Personal journey with type 1 diabetes and connection to diabetes tech09:01 – Exciting developments in diabetes innovation (Aqua Medical, CGMs, etc.)12:26 – Founding story of MedTech Innovator and early competitions15:13 – Lessons learned from failures and avoidable startup mistakes19:09 – Common mistakes founders make (wrong CEO, echo chamber, stealth mode)27:58 – How large medtech companies actually innovate (acquisitions vs. internal R&D)31:02 – The Valley of Death in medtech startups (regulatory vs. commercialization)35:26 – Biggest challenges after approval: evidence, reimbursement, sales traction36:56 – 2024–2025 medtech trends: AI, cardiovascular, neurovascular, robotics, BCI40:49 – What investors really look for: breakthrough vs. incremental innovation44:02 – Founder-investor alignment: understanding timelines and expectations46:59 – The ecosystem MedTech Innovator is building for startups52:01 – Impact of MedTech Innovator: 800+ companies, $10B+ raised54:01 – Upcoming events and competitions (San Diego, October & November)55:36 – Application process for MedTech Innovator: how startups get evaluatedAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #AFib #HealthcareInnovation #Cardiology #AIinHealthcare #StateofMedTech #MedicalDevices
Dr. David Albert has built a career at the intersection of cardiology and technology. Best known as the founder of AliveCor and the creator of KardiaMobile, he shares the story of how a viral YouTube video launched a global digital health company.In this episode, he joins Omar Khateeb to discuss lessons from building multiple startups, the impact of Apple Watch, working with Qualcomm and Vinod Khosla, and what the future of AI-driven cardiology could look like.Episode Breakdown:00:00 – Opening: Every patient is a consumer; AliveCor overview01:17 – Introduction to Dr. David Albert and background03:10 – Early life & education: Harvard, Duke, biomedical engineering09:26 – Mentorship: ECG & cardiology experts guiding career10:26 – Early heart rate monitor development & biomedical engineering training12:03 – Creation of wrist-based heart rate monitor & Doppler ultrasound14:06 – Personal life: meeting future wife15:17 – Early startup: CES presentation, patent challenges18:11 – Family context & balancing entrepreneurship19:02 – Dropping out of training to start a company; first prototype21:03 – Company growth & sales to major medical centers22:31 – Patent litigation & selling company to suing company25:01 – Founding Data Critical & first wireless ECG concept26:07 – Proof of concept & 510(k) clearance27:04 – Sale to GE Healthcare30:03 – Role at GE Healthcare in cardiology34:03 – Founding LiveCor; assembling international team & manufacturing36:45 – YouTube demo video goes viral39:36 – Media coverage: Good Morning America, Fox & CES41:04 – Live demonstration of ECG device42:35 – YouTube success & Eric Topol endorsement44:08 – Early funding & incubation in Silicon Valley47:01 – First-year revenue via veterinary sales to bypass 510(k)48:10 – Regulatory challenges & early adoption48:34 – Continued growth & competition with Apple Watch49:44 – Peer-reviewed publications & clinical validation52:05 – Product evolution: 12-lead & 6-lead devices53:12 – AI integration: ECG cloud & data collection53:45 – Pandemic impact: doubled sales & distribution channels56:04 – Driving adoption: accessibility, pricing, and consumer strategy58:27 – Product adoption, partnerships & global scale59:30 – Future healthcare vision: patient empowerment & preventative focus1:02:02 – AI as essential for continuous health data1:03:33 – Wearables & credit card-sized ECG device1:06:15 – Seamless patient experience & management team1:08:03 – Continuous innovation & blood pressure integration1:08:33 – Cardiovascular prevention mission & strategic partnerships1:10:16 – Advice for entrepreneurs: persistence & problem focus1:15:59 – Early adopters & spreading ideas1:16:34 – Recommended books1:18:17 – Episode closing remarks & call to actionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #Cardiology #DigitalHealth #AI
AI is moving from hype to real-world impact in cardiology. EchoIQ, led by CEO Dustin Haines, is building the world’s only AI platform trained on the largest echocardiogram database. In this conversation, we dive into how their technology improves diagnostic accuracy, reduces workflow friction, and changes the future of heart failure detection.Episode Breakdown:00:00 – Intro: The promise and pitfalls of AI in healthcare 02:04 – Meet Dustin Haines, CEO of EchoIQ 03:38 – Career journey: from pharma to global medtech leadership 06:09 – Why cardiovascular disease remains the world’s #1 killer 07:58 – How EchoIQ closes gaps in misdiagnosis and underdiagnosis 08:57 – Workflow integration: real-time AI results for cardiologists 10:56 – Exclusive access to 2M patient lives in the world’s largest echo database 12:03 – Building 3D phenotypic models vs. traditional image reading 16:15 – How cardiologists are responding to AI adoption 17:57 – Clinical trial results: faster read times, higher efficiency 18:53 – Commercialization and partnerships with hospital systems 22:03 – Tackling IT bottlenecks and integration strategies 25:19 – CPT code hurdles and the role of physician societies 28:38 – EchoIQ’s heart failure solution and Mayo validation study 33:10 – Consumer trends, wearables, and the future of predictive health 36:09 – Exploring partnerships with Apple Watch, AliveCor, and others 37:55 – Expanding access to rural and non-metropolitan patients 39:01 – Acquisition prospects and companion diagnostics opportunities 41:07 – Upcoming conferences and EchoIQ’s focus on clinical data 42:31 – Closing thoughts and where to learn moreAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/ #Medtech #Cardiology #AIinHealthcare #EchoIQ #HeartFailure #MedicalAI #HealthcareInnovation
Venture capital veteran Armen Vidian joins Omar Khateeb to discuss the future of medtech investing, the missing link between tech and healthcare, and what today’s founders must do to attract capital and talent. From the challenges of clinical trials to the opportunity in AI-enabled devices, this conversation dives into the realities of building, funding, and scaling medtech companies in a shifting landscape.Episode Breakdown:00:00 Students of the market and what defines great founders01:32 Armen Vidian’s journey from Racine to MIT to medtech05:00 Lessons from Evolve and Abbott clinical trial pitfalls07:11 Backing Proprio and the small world of medtech investing08:05 Why Recode Ventures looks beyond traditional medtech VC10:40 Attracting talent and capital into medtech12:00 Sales culture versus tech culture in device companies15:01 Why old go to market models no longer work16:45 The incrementalism trap in medtech innovation18:28 When Recode actually invests in devices19:01 Marketing in medtech versus tech what’s missing21:05 Why devices must be intuitive without hand holding22:06 Cybersecurity as a non negotiable for FDA approval25:04 Why tech enabled devices are the real talent magnet28:32 Investor perspectives medtech versus tech risk tolerance31:20 Why Proprio could be Tesla for medtech33:29 Traits of founders who succeed in this space35:02 Why medtech still attracts purpose driven entrepreneurs36:41 Harsh truth lack of AI adoption already cost medtech jobs38:01 Why incremental startups will not get acquired anymore39:09 How closed club dynamics hurt new founders42:09 What full stack medtech companies might look like45:39 Talent pay and career realities in medtech49:25 Lessons from Intuitive Surgical’s rise52:15 Why surgeons deserve better design and experiences55:17 Why disrupting medtech requires respect for its challenges57:01 Books Armen recommends to founders1:01:04 His top advice for entrepreneurs raising nowAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/ #Medtech #VentureCapital #MedicalDevices #HealthcareInnovation #StateofMedTech #AIinHealthcare #Entrepreneurship
Calcified arteries remain one of the toughest challenges in cardiology and peripheral vascular care. Robert Chisena, CTO and co-founder of AVS Pulse Technologies, explains how their intravascular lithotripsy platform uses pulsatile CO₂ energy to fracture calcium safely and effectively.We cover how AVS Pulse differentiates from competitors, the “smart” IVL feedback system, and why this space has become one of the hottest in medtech after multibillion-dollar acquisitions.Episode Breakdown00:00 – Why calcified arterial disease is such a challenge01:22 – Meet Robert Chisena, CTO and co-founder of AVS Pulse Technologies02:01 – How calcium buildup blocks blood flow and leads to serious outcomes03:07 – Why existing technologies struggle with calcium treatment04:42 – AVS Pulse origins at the University of Michigan05:34 – Finding the “chinks in the armor” of calcium06:27 – How pulsatile CO₂ energy fractures calcium07:38 – The water hammer effect explained08:37 – Comparing AVS Pulse to existing lithotripsy devices09:47 – Differentiators: low profile, flexibility, energy efficiency11:14 – 5000 pulses vs rationing with other catheters13:12 – Clinical studies show fast, safe outcomes in complex lesions13:45 – First “smart” IVL device with intra-procedural feedback14:54 – Regulatory pathway and pivotal trials in peripheral and coronary indications17:02 – Promising first-in-human PAD I study results19:07 – How energy delivery reduces dissections compared to other methods21:24 – What happens to calcium once fractured22:01 – Positioning IVL as a prep tool for stenting23:32 – Differentiating IVL from thrombectomy and other treatments23:38 – Funding raised and milestones ahead24:45 – Timeline for commercial launch and next clinical trials25:02 – Upcoming conferences: TCT and VIVA presentations26:08 – Why the market is heating up and where AVS Pulse fits inAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #Leadership #ScottHuennekens #Healthcare #MedicalDevices #Entrepreneurship
What if brain surgery no longer required a scalpel? Dr. Maurice Ferré, CEO of Insightec and co-founder of Mako Surgical, shares how MRI-guided focused ultrasound is redefining neurosurgery.We discuss Insightec’s journey, the 2016 NEJM study that changed everything, and why focused ultrasound could transform treatment for tremor, Parkinson’s, and beyond.Episode Breakdown00:00 – Introduction to the impact of SciTech technology on patient life improvement00:05 – Describing the effects of a one-hour treatment for patients00:49 – Omar's introduction and birthday mention01:09 – Dr. Maurice Ferré’s gratitude for the platform and discussion about the importance of media exposure in medtech03:01 – Maurice’s story about his late friend Yvonne Dalvik and its impact on his drive to work in medtech06:05 – Maurice introduces Insightec and its mission to impact healthcare08:14 – Maurice introduces the concept of focused ultrasound and its commercialization12:01 – Maurice discusses becoming the CEO of Insightec15:00 – InsideTech’s unique approach to focused ultrasound and its technological development18:20 – FDA approval and clinical success in trials23:30 – Maurice shares data on the progress of their procedures and growth in medtech28:00 – Key strategic decisions that positioned Insightec as a leader34:00 – InsideTech’s focus on specific markets and its goal to become the standard of care40:00 – Enhancements in Insightec's technology and how it has revolutionized patient treatment50:00 – Future prospects for focused ultrasound and the drive for patient education and clinical adoption59:00 – Final thoughts on growing Insightec and its innovative approach to treating brain diseases01:03:00 – The crucial role of partnerships and collaborations in growing Insightec01:09:00 – Final reflections and a call to action for the audience to learn more and support the work Insightec is doingAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #Insightec #FocusedUltrasound #Neurosurgery #HealthcareInnovation #MedicalDevices
Every leader has scars from bad decisions. Scott Huennekens, medtech’s “GOAT operator” and board veteran, shares the toughest lessons from his career, including the worst deals he ever made.We cover the six pack of mistakes, why culture and fit matter more than numbers, and how these failures shaped his approach to leadership, boards, and building value.Episode Breakdown:00:00 – Opening and The Challenge of Doing Big Things00:59 – Welcome to the Show: Introducing Scott Huennekens01:36 – The Hard Thing About Hard Things in Medtech03:06 – Defining Your Goals and Identity for Success07:12 – On Knowing Yourself and Exploiting Your Weaknesses08:42 – Why You Should Create a Failure Resume11:30 – Introducing the 'Six Pack' of Learnings12:27 – Mistake #1: The Letterman's Jacket Syndrome16:54 – Mistake #2: Entrepreneurial Intoxication18:54 – Mistake #3: Is the Juice Worth the Squeeze?20:35 – Mistake #4: Less is More and Learning to Say No25:27 – Mistake #5: The Risk of Friends and Family Money27:50 – Mistake #6: CEO, CEO, CEO29:46 – The Investment Criteria Checklist32:42 – Getting Into the 'Pain': Facing Reality and Owning Mistakes34:32 – Case Study #1: The Nova Corps Career Mistake39:43 – Case Study #2: The Ditch Rat CEO Role46:45 – Transition to Investment Mistakes48:42 – Case Study #3: The Wonder Medical Investment54:19 – Case Study #4: The Patara Pharmaceuticals Investment1:05:07 – Case Study #5: The Q's Investment1:17:53 – Final Thoughts and Book RecommendationsAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #Leadership #ScottHuennekens #Healthcare #MedicalDevices #Entrepreneurship
Why are so many strokes in young patients missed? Dr. Thomas Devlin, nationally recognized stroke neurologist and executive medical director at CHI Memorial, explains how robotic transcranial Doppler (TCD) is reshaping stroke and PFO pathways.We cover why TCD is more sensitive than traditional echo, what the Bubble Trial revealed, and how robotic automation is changing workflows in neurology and cardiology.Episode Breakdown 00:00 – Opening and the challenge of detecting PFO with echo 01:11 – Introducing Dr. Thomas Devlin and the Bubble Trial 03:01 – Why strokes in young patients often go unexplained 05:25 – EEG vs robotic TCD: sensitivity and workflow 07:09 – Why PFO must always stay on the differential 10:13 – Meta-analyses and limitations of echo sensitivity 12:29 – Advantages of robotic TCD and real-world performance 15:46 – Benefits for techs and labs: automation and ease of use 16:06 – The Bubble Trial: robotic TCD detects 3x more large shunts 18:02 – Case study: negative echo, positive robotic TCD, large PFO 19:41 – Editorial response and the call for independent validation 20:16 – The Bubble-QE study: real-world validation and outcomes 22:53 – Multicenter results: robotic TCD vs echo and TEE 24:11 – Integrating robotic TCD into national cryptogenic stroke protocols 26:50 – How the Pascal score guides closure decisions 30:00 – Economics: reimbursement and hospital adoption 33:05 – Building trust between neurologists and cardiologists 35:00 – Guidelines and national rollout of robotic TCD 37:05 – Comparing manual vs robotic: why automation wins 42:54 – Structure, incentives, and improving stroke workups 46:47 – Who “owns” the neurovascular lab: neurology vs cardiology 50:16 – Reimbursement and payer considerations 55:38 – Lessons from emerging economies and value-based innovation 58:13 – Future use cases: ambulance, helicopter, and OR monitoring 1:03:34 – Final thoughts and why this is the third chapter of stroke innovationAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Stroke #Medtech #PFO #Robotics #Diagnostics #HealthcareInnovation
Every 20 seconds, someone in the world loses a limb to diabetes. Many of these amputations could be prevented with earlier detection. In this episode, Amaan Mazhar, CEO of Modulim, explains how handheld imaging can spot circulation issues before ulcers form. We cover the science behind spatial frequency domain imaging, the economics of diabetic foot ulcers, and how proactive screening can save both lives and costs.Episode Breakdown00:00 – The epidemic of lower limb complications in the US 02:01 – Amaan Mazhar’s journey into medtech and imaging science 03:38 – From UC Irvine research to founding Modulim 04:52 – Diabetic foot ulcers and why they are so costly 05:27 – Traditional foot checks and why they often fail 07:02 – Modulim’s imaging: seeing below the skin surface 09:17 – Biomarkers that predict wounds before they form 10:52 – Case study: detecting an ulcer 13 weeks before it appeared 12:06 – Spatial frequency domain imaging explained 13:23 – Pivot from cart system to handheld device 15:54 – Reducing manufacturing costs and expanding access 17:18 – Identifying micro vs macrovascular issues18:55 – Clinical traction with Kaiser Permanente and Fresenius 20:27 – Commercial model: hardware placement plus software subscription 22:01 – Expanding into military use for wound and burn assessment 25:03 – How the technology works: light patterns, multispectral imaging 27:21 – IP, UC Irvine partnership, and innovation pathway 28:10 – Regulatory strategy: 510(k) submission for handheld device29:35 – Market opportunity: 30–40 million patients at risk 31:04 – Early detection as a data gap and how Modulim can close it 32:28 – Closing thoughts and call to actionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #Diabetes #AmputationPrevention #Diagnostics #HealthcareInnovation #DigitalHealth
What does it take to close the innovation gap in cardiology? Dr. Mohamad Alkhouli, professor of medicine and vice chair for strategic partnerships at Mayo Clinic, shares his perspective on AI, health span vs lifespan, and why structure drives behavior in healthcare.This episode covers the future of multimodal AI, global innovation, and why doctors who embrace AI will lead the next generation of medicine.Episode Breakdown 00:00 – Opening: AI as a personal coach and changing education 01:11 – Introducing Dr. Mohamad Alkhouli and Mayo Clinic Innovation Summit 03:01 – The innovation gap in cardiology explained 03:38 – Lifespan vs health span and the 11-year gap 04:11 – The cost of innovation and unsustainable healthcare spending 07:09 – Three main reasons behind the innovation gap 08:18 – Population-based models vs individual realities 09:04 – The problem with fragmentation in medicine 11:14 – Why grounding in pathophysiology matters 16:16 – From AI skepticism to embracing its role in decision-making 17:48 – Lessons from Waymo and the “extra eyes” analogy 20:29 – AI in code: new insights from old angiograms 22:28 – Multimodal AI and the future of cardiology diagnostics 25:27 – Why multimodal biomarkers will redefine disease classification 27:01 – How AI already improves procedural safety 28:02 – Mayo Clinic’s in-house AI models and the Mayo Clinic Platform 29:49 – Salience mapping and explainable AI 32:40 – AI in medical education and generational differences 36:18 – Redefining health: from WHO 1948 to dynamic health models 42:54 – Structure drives behavior in innovation and healthcare systems 45:20 – Democratizing innovation and involving frontline clinicians 48:06 – Why reimbursement and payer models matter for adoption 50:16 – ECG-based AI detection of aortic stenosis 52:09 – Pushback from payers and systemic barriers 55:38 – Value-based innovation and lessons from emerging economies 58:13 – Planning the next Mayo Clinic Innovation Summit 1:01:03 – The role of AI in connecting specialties and future training 1:02:25 – The Mayo AI Summit and opportunities to join 1:03:34 – Final thoughts: doctors who use AI vs doctors who don’t 1:04:22 – What’s in your AI stack? Omar and Dr. Alkhouli share their toolsAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#AI #Cardiology #Medtech #MayoClinic #DigitalHealth
Stephanie Broes, CEO and co-founder of Moonbird, shares how breathwork can improve sleep, stress, and HRV.From insomnia during her PhD to creating a tactile breathing device, Stephanie explains how science and design came together to build a product that is helping adults, children, and even parents navigate stress and rest.Episode Breakdown: 00:00 – How changing your breathing changes your sleep and mood01:21 – Meet Stephanie Broes and the story of Moonbird02:59 – From PhD scientist to health tech entrepreneur04:52 – Insomnia, stress, and the discovery of breathwork06:22 – Designing Moonbird and why the avocado shape worked10:33 – The story behind the Moonbird name12:05 – Breathwork and the nervous system explained15:13 – Heart rate variability (HRV) and why it matters17:04 – How Moonbird boosts HRV and supports sleep19:00 – Unexpected users: kids, ADHD, menopause, autism22:01 – Launching Moonbuddy for children25:22 – Co-creating products with parents and clinicians27:05 – Wellness market growth and scaling in the US29:00 – Marketing lessons: ads, PR, partnerships, insurance31:04 – Consumer vs. medical device strategy32:29 – Using Moonbird with or without the app33:19 – Real-time HRV, coherence, and biofeedback34:40 – Clinical studies and published results36:52 – Long-term vision: making breathwork mainstream39:08 – Handling criticism: “Why buy what’s free?”42:15 – Roadmap: AI, personalization, and integration with wearables43:30 – Closing thoughts and call to actionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Breathwork #Sleep #Moonbird #StressRelief #Medtech #DigitalHealth #Wellness
NFL veteran Leonard Wheeler opens up about his prostate cancer journey, from early PSA screening to diagnosis and the treatment decision that preserved both his health and quality of life.He talks about conversations with family, facing fear, recovery, and why men must start speaking openly about prostate cancer.Episode Breakdown00:00 – Opening: No signs, just rising PSA trends01:02 – Meet Leonard Wheeler: NFL career and life after football05:11 – PSA checks, biopsy, and the moment fear set in08:55 – Talking with family: wife, children, and support system13:00 – Shame, silence, and why men struggle to share health news17:05 – From prostatectomy options to learning about ablation22:23 – Fear of side effects: continence, intimacy, and identity25:04 – A friend introduces the idea of focal therapy27:10 – Why a minimally invasive procedure became the choice30:45 – Recovery: catheter, walking miles, and regaining confidence33:12 – Faith, friends, and a dream of advocacy36:00 – Explaining the procedure step by step42:30 – Quality-of-life focus: protecting intimacy and dignity46:14 – Family, prayer circles, and the role of support networks49:11 – Why men do not talk about prostate cancer and why they must52:24 – Creating a movement: awareness, ribbons, and brotherhood55:07 – Leonard’s book Beyond the Locker Room and his missionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #LungCancer #Diagnostics #Pulmonology #HealthcareInnovation
Lung cancer remains the most lethal cancer worldwide, and traditional biopsy approaches still leave critical gaps. In this episode, interventional pulmonologist Dr. Steven Kovacs shares how real-time metabolic imaging inside the bronchoscopy suite is transforming how clinicians assess biopsy adequacy.Episode Breakdown00:00 – Opening remarks: the challenge of lung cancer diagnosis01:17 – Introducing Dr. Steven Kovacs02:11 – Journey through bronchoscopy: from navigation to robotics05:11 – The problem with current biopsy yields and ROSE07:29 – Why imaging tool-in-lesion is not enough09:59 – Metabolic activity as a new “PET scan for cells”12:16 – How dynamic cell imaging works in real time14:45 – Preserving tissue for pathology and sequencing17:15 – Differentiating inflammation, necrosis, and malignancy in the same lesion19:37 – Case studies: when pathology said “negative,” but malignancy was present22:01 – Adequacy as a clinical responsibility, not just pathology’s burden24:07 – The future of bronchoscopy workflows and precision medicine27:32 – Audience Q&A: diagnostic adequacy and workflow efficiency30:52 – Audience Q&A: reducing procedure time and anesthesia costs34:41 – Audience Q&A: handling tissue and specimen prep38:18 – Audience Q&A: impact on indeterminate biopsies43:12 – Audience Q&A: adequacy for NGS and downstream testing47:20 – Hospital administration and value analysis: time savings and cost impact50:05 – Surgical use cases and margin evaluation52:25 – Adoption and workflow integration: overcoming learning curves53:32 – Closing thanks and replay reminderAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/#Medtech #LungCancer #Diagnostics #Pulmonology #HealthcareInnovation